🇺🇸 FDA
Patent

US 6099842

Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diptheria toxin

expired A61KA61K38/00

Quick answer

US patent 6099842 (Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diptheria toxin) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Aug 08 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/00